|
| [15] | R. Benedé-Ubieto, O. Estévez-Vázquez, F. Guo, C. Chen, Y. Singh, H. I. Nakaya, M. Gómez Del Moral, A. Lamas-Paz, L. Morán, N. López-Alcántara, J. Reissing, T. Bruns, M. A. Avila, E. Santamaría, M. S. Mazariegos, M. M. Woitok, U. Haas, K. Zheng, I. Juárez, J. M. Martín-Villa, I. Asensio, J. Vaquero, M. I. Peligros, J. Argemi, R. Bataller, J. Ampuero, M. Romero Gómez, C. Trautwein, C. Liedtke, R. Bañares, F. J. Cubero, Y. A. Nevzorova,
"An Experimental DUAL Model of Advanced Liver Damage", Hepatology communications, vol. 5, no. 6, 2021, pp. 1051–1068.
|
| [14] | O. Estévez-Vázquez, R. Benedé-Ubieto, F. Guo, B. Gómez-Santos, P. Aspichueta, J. Reißing, T. Bruns, C. Sanz-García, S. Sydor, L. P. Bechmann, E. Maranillo, J. R. Sañudo, M. T. Vázquez, A. Lamas-Paz, L. Morán, M. S. Mazariegos, A. Ciudin, J. M. Pericàs, M. I. Peligros, J. Vaquero, E. Martínez-Naves, C. Liedtke, J. R. Regueiro, C. Trautwein, R. Bañares, F. J. Cubero, Y. A. Nevzorova,
"Fat", Biomedicines, vol. 9, no. 10, 2021, pp. 1289.
|
| [13] | N. Guldiken, J. Argemi, B. Gurbuz, S. R. Atkinson, M. Oliverius, P. Fila, K. Hamesch, T. Bruns, J. Cabezas, J. J. Lozano, J. Mann, S. Cao, P. Mathurin, V. H. Shah, C. Trautwein, M. R. Thursz, R. Bataller, P. Strnad,
"Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases", BMC medicine, vol. 19, 2021, pp. 39.
|
| [12] | K. Große, D. Ohm, S. Würstle, J. F. Brozat, R. M. Schmid, C. Trautwein, A. Stallmach, T. Bruns, P. A. Reuken,
"Clinical characteristics and outcome of patients with enterococcal liver abscess", Scientific reports, vol. 11, no. 1, 2021, pp. 22265.
|
| [11] | C. V. Schneider, M. Fromme, K. M. Schneider, T. Bruns, P. Strnad,
"Mortality in Patients With Genetic and Environmental Risk of Liver Disease", The American journal of gastroenterology, vol. 116, no. 8, 2021, pp. 1741–1745.
|
| [10] | K. Schubert, I. Karkossa, J. Schor, B. Engelmann, L. M. Steinheuer, T. Bruns, U. Rolle-Kampczyk, J. Hackermüller, M. von Bergen,
"A Multi-Omics Analysis of Mucosal-Associated-Invariant T Cells Reveals Key Drivers of Distinct Modes of Activation", Frontiers in immunology, vol. 12, 2021, pp. 616967.
|
| [9] | J. Voss, C. V. Schneider, M. Kleinjans, T. Bruns, C. Trautwein, P. Strnad,
"Hepatobiliary phenotype of individuals with chronic intestinal disorders", Scientific reports, vol. 11, 2021, pp. 19954.
|
| [8] | T. Wirtz, P. A. Reuken, C. Jansen, P. Fischer, I. Bergmann, C. Backhaus, C. Emontzpohl, J. Reißing, E. F. Brandt, M. T. Koenen, K. M. Schneider, R. Schierwagen, M. J. Brol, J. Chang, H. W. Zimmermann, N. Köse-Vogel, T. Eggermann, I. Kurth, C. Stoppe, R. Bucala, J. Bernhagen, M. Praktiknjo, A. Stallmach, C. Trautwein, J. Trebicka, T. Bruns, M. Berres,
"Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis", JHEP reports, vol. 3, no. 2, 2021, pp. 100221.
|
|
| [7] | J. F. Brozat, F. Hanses, M. Haelberger, M. Stecher, M. Dreher, L. Tometten, M. M. Ruethrich, J. J. Vehreschild, C. Trautwein, S. Borgmann, M. J. G. T. Vehreschild, C. E. M. Jakob, A. Stallmach, K. Wille, K. Hellwig, N. Isberner, P. A. Reuken, F. Geisler, J. Nattermann, T. Bruns, L. study group,
"COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry", United european gastroenterology journal, vol. 10, no. 4, 2022, pp. 409–424.
|
| [6] | E. Gardey, F. H. Sobotta, S. Quickert, T. Bruns, J. C. Brendel, A. Stallmach,
"ROS-Sensitive Polymer Micelles for Selective Degradation in Primary Human Monocytes from Patients with Active IBD", Macromolecular bioscience, vol. 22, no. 4, 2022, pp. 2100482.
|
| [5] | F. Guo, O. Estévez-Vázquez, R. Benedé-Ubieto, D. Maya-Miles, K. Zheng, R. Gallego-Durán, . Rojas, J. Ampuero, M. Romero-Gómez, K. Philip, I. U. Egbuniwe, C. Chen, J. Simon, T. C. Delgado, M. L. Martínez-Chantar, J. Sun, J. Reissing, T. Bruns, A. Lamas-Paz, M. G. D. Moral, M. M. Woitok, J. Vaquero, J. R. Regueiro, C. Liedtke, C. Trautwein, R. Bañares, F. J. Cubero, Y. A. Nevzorova,
"A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy", Cancers, vol. 14, no. 1, 2022, pp. 192.
|
| [4] | M. Kleinjans, C. V. Schneider, T. Bruns, P. Strnad,
"Phenome of coeliac disease vs. inflammatory bowel disease", Scientific reports, vol. 12, 2022, pp. 14572.
|
| [3] | S. Quickert, S. Würstle, P. A. Reuken, S. Hagel, J. Schneider, R. M. Schmid, S. Neugebauer, A. Stallmach, T. Bruns,
"Real-World Effectiveness of Piperacillin/Tazobactam with and without Linezolid for Spontaneous Bacterial Peritonitis", Digestive diseases, vol. 40, no. 6, 2022, pp. 777–786.
|
| [2] | P. A. Reuken, J. F. Brozat, S. Quickert, O. Ibidapo-obe, J. Reißing, A. Franz, S. Stengel, U. K. Teichgräber, M. Kiehntopf, C. Trautwein, A. Stallmach, A. Koch, T. Bruns,
"Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis", Journal of Intensive Care, vol. 10, no. 1, 2022, pp. 28.
|
|
| [1] | B. Gurbuz, N. Guldiken, P. Reuken, L. Fu, K. Remih, C. Preisinger, R. Brůha, M. Leníček, J. Petrtýl, J. Reißing, M. Aly, M. Fromme, B. Zhou, I. Karkossa, K. Schubert, M. von Bergen, A. Stallmach, T. Bruns, P. Strnad,
"Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis", Hepatology international, vol. 17, no. 3, 2023, pp. 698–708.
|